Search

Search Constraints

You searched for: Author/Creator Zeng, Z.

Search Results

1. A phase Ib trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors. (December 2016)

4. Baseline hepatitis B core antibody predicts treatment response in chronic hepatitis B patients receiving long‐term entecavir. Issue 2 (28th November 2016)